2025-521771-31-00RecruitingPhase 1
Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer
Source: EU CTIS (euclinicaltrials.eu) · Last updated 19 Aug 2025 · Not updated for over 12 months - ask the site whether it is still open
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- First submitted
- 14 May 2025
- Start date
- 5 Jan 2026
- Lead sponsor
- Universitair Medisch Centrum Groningen
- Diseases
- Cervical cancer
- EU CT number
- 2025-521771-31-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 12
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women with cervical cancer. It tests an immunotherapy given as an injection under the skin.
- Age
- 18 years or older
- Sex
- Women only
Read by machine on 9 Nov 2026.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitair Medisch Centrum Groningen | Groningen | Netherlands | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.